Neurodegenerative Diseases
Neurology·MeSH: Neurodegenerative Diseases
6 drugs in development·5 companies·8 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| latozinemab | Alector, Inc. (ALEC) |
Phase 2(2)
Phase 1(1)
| Drug | Company |
|---|---|
| PRX019 | PROTHENA CORP PUBLIC LTD CO (PRTA) |
Preclinical(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Neurodegenerative Diseases?
BioSniper tracks 6 drugs in development for Neurodegenerative Diseases across 5 companies.
How many clinical trials target Neurodegenerative Diseases?
There are 8 clinical trials targeting Neurodegenerative Diseases tracked by BioSniper.
Deep-dive into Neurodegenerative Diseases
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis